Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
Synthesis, biological activity, and ADME properties of novel S-DABOs/N-DABOs as HIV reverse transcriptase inhibitors.
The HR2 polymorphism N140I in the HIV-1 gp41 combined with the HR1 V38A mutation is associated with a less cytopathic phenotype.
Canine hepacivirus NS3 serine protease can cleave the human adaptor proteins MAVS and TRIF.
Adenosine deaminase enhances the immunogenicity of human dendritic cells from healthy and HIV-infected individuals.
Siglec-1 is a novel dendritic cell receptor that mediates HIV-1 trans-infection through recognition of viral membrane gangliosides.
Relationship between minority nonnucleoside reverse transcriptase inhibitor resistance mutations, adherence, and the risk of virologic failure.
European recommendations for the clinical use of HIV drug resistance testing: 2011 update.
Dynamic imaging of cell-free and cell-associated viral capture in mature dendritic cells.
HIV-1 requires Arf6-mediated membrane dynamics to efficiently enter and infect T lymphocytes.
Impact of phenotype definition on genome-wide association signals: empirical evaluation in human immunodeficiency virus type 1 infection.